3.1 Targeted Therapy - Shah

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/55

flashcard set

Earn XP

Description and Tags

idk fam

Last updated 12:50 AM on 4/22/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

56 Terms

1
New cards

what is targeted therapy?

A cancer treatment that targets proteins/genes associated with growth and metastasis of cancer

2
New cards

targeted therapy acts on _________

specific molecular targets

3
New cards

targeted therapy is ____ and chemotherapy is ____

a. cytotoxic, cytotoxic

b. cytostatic, cytotoxic

c. cytotoxic, cytostatic

d. cytostatic, cytostatic

b

4
New cards

chemotherapy acts on…

all rapidly dividing cells

5
New cards

why is companion diagnosis essential for targeted therapy? (3)

  1. can tell if a pt would benefit from a specific targeted therapy

  2. can tell if a pt would be at a higher risk for ADE from specific targeted therapies

  3. can monitor treatment and progression in pts on targeted therapy

6
New cards

name the two types of targeted therapy

small molecule inhibitors

monoclonal antibodies

7
New cards

how do small molecule inhibitors work?

they enter cells and inhibit intracellular targets

8
New cards

SMIs:

  1. admin route

  2. typical targets

  1. oral

  2. kinases

9
New cards

monoclonal antibodies targets are …

on the cell surface

10
New cards

Which targets intracellular pathways?

a. small molecule inhibitors

b. monoclonal antibodies

a

11
New cards

mabs admin route

IV

12
New cards

common ADE of all targeted therapies (3)

diarrhea, liver problems, and skin problems

13
New cards

other ADE of targeted therapies include… (6)

HTN

Fatigue

Rash

Mouth sores

Nail changes

Loss of hair color

14
New cards

Which oncogene is most commonly mutated?

RAS

15
New cards

What happens when Ras is mutated?

cancer growth due to constant activation

16
New cards

what type of receptor is EGFR?

tyrosine kinase receptors

17
New cards

when EGFR is activated, it leads to…

increased proliferation

increased metastasis

decreased apoptosis

18
New cards

cells expressing EGFR are resistant to…

cytotoxins

19
New cards

Which receptor is important in breast cancer?

HER2

20
New cards

of the HER dimers, which is the most potent and activates RAS MAPK and the STAT pathways?

HER1/HER2

21
New cards

Cetuximab

  1. class

  2. what is its target?

  1. mab

  2. EGFRs

22
New cards

Erbitux

  1. mab or SMI?

  2. what is its target?

  1. mab

  2. EGFR

23
New cards

name 2 mabs that target EGFR

Cetuximab

Erbitux

24
New cards

which drugs targets HER2

Trastuzumab

pertizumab

25
New cards

pertizumab

  1. mab or SMI?

  2. target?

  1. mab

  2. HER2

26
New cards

Trastuzumab

  1. mab or SMI?

  2. target?

  1. mab

  2. HER2

27
New cards

Trastuzumab MOA

downregulates HER2 signaling by masking protease cleavage site and blocking shedding of the receptor

ultimately leads to activation of the TK domain to

28
New cards

panitumumab

  1. mab or SMI?

  2. target

  1. mab

  2. EGFR

29
New cards

consequences of HER targeted therapies

drug resistance

30
New cards

name 4 tyrosine kinase inhibitors

Afatinib

Erlotinib

getitinib

osimertinib

31
New cards

Afatinib

  1. mab or SMI?

  2. target

  3. fatal ADE

  1. SMI

  2. TK EGFR, HER 2, and HER4

  3. intersitial lung disease, sepsis, and pneumonia

32
New cards

Erlotinib

  1. mab or SMI?

  2. target

  3. most common ADE

  1. SMI

  2. TK EGFR

  3. rash and diarrhea

33
New cards

Gefitinib

  1. mab or SMI?

  2. target

  1. SMI

  2. TK EGFR

34
New cards

Osimertinib

  1. class

  2. target

  1. SMI

  2. TK EGFR

35
New cards

Sunitinib

  1. mab or SMI?

  2. target

  1. SMI

  2. EGFR

36
New cards

Sorafenib

  1. mab or SMI?

  2. target

  1. SMI

  2. multikinase, serine, threonine, and tyrosine kinases

37
New cards

what does ALK code for

tyrosine kinases

38
New cards

MOA of ALK tyrosine kinase inhibitors

competitive inhibition of the ATP binding site on the ALK receptor

39
New cards

cizotinib

  1. class

  2. target

  1. SMI

  2. ALK receptor

40
New cards

ceritinib

  1. mab or SMI?

  2. target

  1. SMI

  2. tyrosine kinase, ALK, IGF1, and ROS1

41
New cards

Alectinib

  1. class

  2. target

  1. SMI

  2. ALK and RET

42
New cards

Lorlatinib

  1. class

  2. target

  1. SMI

  2. ALK and ROS1

43
New cards

Brigatinib

  1. class

  2. target

  1. SMI

  2. ALK and ROS1

44
New cards

what proteins are considered molecular switches?

RAS

45
New cards

Dabrafenib

  1. class

  2. target

  3. severe ADE

  1. SMI

  2. BRAF

  3. carcinoma, hypotension, kidney failure

46
New cards

name the MEK inhibitor

Trametinib

47
New cards

Trametinib

  1. class

  2. target

  3. ADE

  1. SMI

  2. MEK

  3. rash, diarrhea, edema

48
New cards

name the CDK inhibitor

Palbociclib

49
New cards

name the PI3K inhibitor

Idelalisib

50
New cards

name the mTOR inhibitor

Everolimus

51
New cards

what pathway promotes growth / proliferation

RAS / MAPK

52
New cards

what pathway promotes survival (anti-apoptosis)

PI3K / AKT / mTOR

53
New cards

which pathway promotes the cell cycle division

CDK

54
New cards

name the proteins that are pro-apoptosis

BAD

NOXA

BAX

BAK

55
New cards

name the proteins that are anti-apoptosis

Bcl-2

Bcl-xl

56
New cards

Which of the following does not promotes apoptosis?

a. bcl-2

b. NOXA

c. BAD

d. BAK

a